Faeth Therapeutics Financials - Benzinga

Faeth Therapeutics Inc

FTHNASDAQ

Trade with Public

Trade with Public

$33.84

0.100.3%

At close: Aug 28, 5:00 PM EST

$33.84

N/A

After Hours: Aug 28, 4:00 PM EST

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Compare Stock Report

Faeth Therapeutics Financials

Faeth Therapeutics (FTH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Faeth Therapeutics Q2 EPS $(2.84) Beats $(3.29) Estimate

Faeth Therapeutics (NASDAQ:FTH) reported quarterly losses of $(2.84) per share which beat the analyst consensus estimate of $(3.29) by 13.68 percent. This is a 27.37 percent increase over losses of $(3.91) per share

Benzinga Newsdesk